At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Feb 24, 2026 at 19:00 ET
Two Vertex Pharmaceuticals EVPs, the Chief Commercial Officer and Chief Legal Officer, sold shares in open-market transactions totaling approximately $1.6 million over the past week. These were opportunistic sales of existing holdings, not tied to a specific corporate event.
- EVP and Chief Commercial Officer Duncan McKechnie sold 2,437 shares for $1,158,306.10 at $475.30 per share on March 4, 2026.
- EVP and Chief Legal Officer Joy Liu sold 892 shares for $442,396.32 at $495.96 per share on March 2, 2026.
- Total value of the insider trading cluster: $1,600,702.42 in open-market sales.
- Both transactions were reported on Form 4 as open-market sales (code 'S'), indicating deliberate dispositions.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access